https://www.selleckchem.com/products/pu-h71.html
The treatment responses suggested a significant difference (P 0.001) between OXC and other anti-epileptic drugs. OXC as a sodium channel blocker may have a better effect than LEV and VPA in the treatment of PRRT2-associated SFIE. PRRT2 variants may be used as a biomarker to help select antiepileptic drugs for SFIE. OXC as a sodium channel blocker may have a better effect than LEV and VPA in the treatment of PRRT2-associated SFIE. PRRT2 variants may be used as a biomarker to help select antiepileptic drugs for SFIE. Fluoride and calc
Like
Comment
Share
